Tanglewood Legacy Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-100
Closed -$26.1K 295
2024
Q4
$26.1K Hold
100
0.01% 210
2024
Q3
$32.2K Hold
100
0.01% 184
2024
Q2
$31.2K Hold
100
0.01% 187
2024
Q1
$28.4K Hold
100
0.01% 194
2023
Q4
$28.8K Hold
100
0.02% 185
2023
Q3
$26.9K Hold
100
0.02% 194
2023
Q2
$22.2K Hold
100
0.01% 209
2023
Q1
$24.2K Hold
100
0.02% 193
2022
Q4
$26.3K Buy
+100
New +$26.8K 0.02% 169

Other funds holding AMGN

Tanglewood Legacy Advisors's AMGN Position: Q1 2025 in Review

Tanglewood Legacy Advisors sold out of Amgen (AMGN) in Q1 2025, closing a stake of 100 shares — an estimated $26.1K sold.

Tanglewood Legacy Advisors first reported a position in AMGN in Q4 2022 and held it in 9 quarters. The position peaked at $32.2K in Q3 2024. 2,927 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Tanglewood Legacy Advisors reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Tanglewood Legacy Advisors sold 100 Amgen shares in Q1 2025, an estimated $26.1K.
  • Tanglewood Legacy Advisors first reported a position in Amgen in Q4 2022 and held it in 9 quarters.
  • Tanglewood Legacy Advisors's Amgen position peaked at $32.2K in Q3 2024.
  • 2,927 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Tanglewood Legacy Advisors's 13F filing for Q1 2025, filed 22 Apr 2025.